SRD5A3 and urinary bladder carcinoma: Our results revealed an upregulation of SRD5A3 in bladder cancer tissues and SRD5A3 knockdown could reduce bladder cancer cell proliferation, prevent CDDP resistance, induce cell apoptosis, and inhibit bladder tumorigenesis in mice.